Argentina caps liraglutide prescribing to 5 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
The archive
Page 129 of 170 of this archive, newest first.
A schedule that bends does not break
Nausea and gastric delay attenuate over weeks at an unchanged dose. That single physiological fact is the entire justification for holding.
The limits of mechanism: why receptor data will not tell you who responds
The mechanism is well described. The variance is not.
A shortage listing ends. 17 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
SURPASS-2 misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
Canada health authority warns on falsified liraglutide pens
Reported from the analysis, not from a warning notice.
Accreditation, scope, and the question nobody asks PeptideMeter
Two signatures — one who performed the work, one who approved its release — are the ordinary regulated convention and are almost unknown here.
What the placebo arms of the withdrawal trials actually tell us
The evidence on stopping is better than the evidence on almost anything else in this field, because somebody deliberately randomised it.
The four testing services and the study none of them can run
Storage instructions in this market are close to uniform and almost never accompanied by the study that would justify them. Uniformity is a sign of convention, not of…
What changed at QST in August, and what the company says prompted it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
A shortage listing ends. 13 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
Diminishing returns, quantified
Where the curve flattens, what flattens with it, and what does not.
Homopeptide names the synthesis and fill sites behind its catalogue
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The 31-day notice: how a compounding wind-down works in Italy
The document is four pages. Three of them are about dates.
From the floor in Xianning: 23 posters, one theme
Reported from the sessions, and from the two hours afterwards.
Mexico caps dulaglutide prescribing to 18 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
The glycated haemoglobin assay, and the eight conditions that break it
The alternatives with shorter windows, what they measure, and why they are rarely ordered.
The empty half of every certificate of analysis
Purity, content, identity, sterility and endotoxin are five separate determinations. A single sheet of paper carrying one of them is not evidence about the other four.
A supplier suspends shipping to France after 7 consecutive customs detentions
The route did not close because of a rule about peptides.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
The United Arab Emirates declines to reimburse semaglutide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
The area postrema, and the anatomy of an unwanted effect
A single drug producing both constipation and diarrhoea looks contradictory until the motility data is read properly.
The question no chromatogram has ever answered
The Journal has read several hundred certificates from twenty companies. We set out what the documents actually cover, and what a reader is filling in from imagination.
Inspectors cite the relabeller trading as Vantris Bio over sterility assurance
The observation that closes a facility is rarely the dramatic one.
What the new the Netherlands guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
MKM names the synthesis and fill sites behind its catalogue
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The United Arab Emirates declines to reimburse liraglutide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
A peak with no chromophore is a peak with no peak
Non-chromophoric components — counter-ions, salts, some excipients — contribute mass to the vial and nothing at all to the chromatogram.